In a report to the FDA, Merck says it has figured out how its blockbuster Type 2 diabetes drugs have become contaminated with nitrosamine. And the company has told the regulator that it can fix the ...

After years of battling over the patents on blockbuster diabetes drug Januvia, Merck and its generic rival Viatris are ready to put the case to rest. In a recent filing with the U.S. District Court ...

Merck’s (NYSE:MRK) Alimentary & Metabolism drugs account for around 10% of the company’s value, according to our estimates. The key drugs in this segment are Januvia and Janumet. We don’t expect any ...

Pharmaceutical company Merck said that it is working to reduce levels of a cancer-causing organic compound that was found in some of its popular type 2 diabetes drugs. The compound, called ...

Januvia comes as a tablet that you swallow. Keep reading for details on Januvia and cost, and how to save money on prescriptions. Note: For more details on Januvia, see this in-depth article. The ...

Merck stock has become dependent on its diabetes drug Januvia over the past couple of years for revenue growth. The franchise made up 12% of Merck's sales in the first quarter and probably a larger ...

KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the primary results of the Trial Evaluating Cardiovascular Outcomes with ...